Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Prostate Cancer and Prostatic Diseases
|
November 11, 2009
Utility and health-related quality of life in prostate cancer patients 12 months after radical prostatectomy or radiation therapy
M D Krahn, K E Bremner, G Tomlinson, et al.
Drugs & Aging
|
September 1, 1995
Recent advances in geriatric psychopharmacology
C A Naranjo, N Herrmann, N Mittmann, et al.
Prostate Cancer and Prostatic Diseases
|
October 16, 2013
Predicting utility scores for prostate cancer: mapping the Prostate Cancer Index to the Patient-Oriented Prostate Utility Scale (PORPUS)
K E Bremner, N Mitsakakis, L Wilson, et al.
Clinical Pharmacology and Therapeutics
|
August 1, 1997
Using fuzzy logic to predict response to citalopram in alcohol dependence
C A Naranjo, K E Bremner, M Bazoon, et al.
Clinical Pharmacology and Therapeutics
|
June 1, 1992
Citalopram decreases desirability, liking, and consumption of alcohol in alcohol-dependent drinkers
C A Naranjo, C X Poulos, K E Bremner, et al.
British Journal of Addiction
|
June 1, 1992
Eating disorders and alcohol abuse in women
D S Goldbloom, C A Naranjo, K E Bremner, et al.
International Clinical Psychopharmacology
|
September 1, 1994
Fluoxetine attenuates alcohol intake and desire to drink
C A Naranjo, C X Poulos, K E Bremner, et al.
Current Oncology (Toronto, Ont.)
|
June 19, 2014
Health care costs for prostate cancer patients receiving androgen deprivation therapy: treatment and adverse events
M D Krahn, K E Bremner, J Luo, et al.
Journal of Clinical Psychopharmacology
|
February 1, 2000
Long-term benzodiazepine therapy does not result in brain abnormalities
U E Busto, K E Bremner, K Knight, et al.
Journal of Psychiatry & Neuroscience : JPN
|
March 20, 1998
Safety of ipsapirone treatment compared with lorazepam: discontinuation effects
U E Busto, C A Naranjo, K E Bremner, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Prostate Cancer and Prostatic Diseases
|
November 11, 2009
Utility and health-related quality of life in prostate cancer patients 12 months after radical prostatectomy or radiation therapy
M D Krahn, K E Bremner, G Tomlinson, et al.
Drugs & Aging
|
September 1, 1995
Recent advances in geriatric psychopharmacology
C A Naranjo, N Herrmann, N Mittmann, et al.
Prostate Cancer and Prostatic Diseases
|
October 16, 2013
Predicting utility scores for prostate cancer: mapping the Prostate Cancer Index to the Patient-Oriented Prostate Utility Scale (PORPUS)
K E Bremner, N Mitsakakis, L Wilson, et al.
Clinical Pharmacology and Therapeutics
|
August 1, 1997
Using fuzzy logic to predict response to citalopram in alcohol dependence
C A Naranjo, K E Bremner, M Bazoon, et al.
Clinical Pharmacology and Therapeutics
|
June 1, 1992
Citalopram decreases desirability, liking, and consumption of alcohol in alcohol-dependent drinkers
C A Naranjo, C X Poulos, K E Bremner, et al.
British Journal of Addiction
|
June 1, 1992
Eating disorders and alcohol abuse in women
D S Goldbloom, C A Naranjo, K E Bremner, et al.
International Clinical Psychopharmacology
|
September 1, 1994
Fluoxetine attenuates alcohol intake and desire to drink
C A Naranjo, C X Poulos, K E Bremner, et al.
Current Oncology (Toronto, Ont.)
|
June 19, 2014
Health care costs for prostate cancer patients receiving androgen deprivation therapy: treatment and adverse events
M D Krahn, K E Bremner, J Luo, et al.
Journal of Clinical Psychopharmacology
|
February 1, 2000
Long-term benzodiazepine therapy does not result in brain abnormalities
U E Busto, K E Bremner, K Knight, et al.
Journal of Psychiatry & Neuroscience : JPN
|
March 20, 1998
Safety of ipsapirone treatment compared with lorazepam: discontinuation effects
U E Busto, C A Naranjo, K E Bremner, et al.
Page
of 3